Genome-first analyses in UK Biobank and All of Us support RBM20 as an arrhythmogenic DCM gene, with an etiologic fraction of ...

Weight-loss responses to GLP-1 obesity drugs, and risks of side effects, may be linked to genetic variants, according to a ...

Exclusive: Pre-chemotherapy tests previously did not look for gene variant that put some ethnicities at higher risk of serious side effects ...

New rare genetic variants are linked to ALS, expanding understanding of genetic contributors. About a quarter of ALS cases have an identifiable genetic contributor. Findings support broader use of ...

Type 1 diabetes is an autoimmune condition in which the body attacks its own insulin-producing cells in the pancreas. Some ...

More than a quarter of people with Type 2 diabetes take GLP-1 receptor agonists, but the popular diabetes drugs might not ...

Egypt has identified more than 17 million previously undocumented genetic variants in its first large-scale genome study, ...

Scientists have identified genetic variants associated with slightly greater weight loss and the incidence of side effects in people taking glucagon-like peptide-1 (GLP-1) receptor agonists. The ...

Rare telomere and non-telomere genetic variants significantly affect survival in IPF patients, with non-additive effects on common risk variants. Polygenic risk scores (PRS-IPF) may play a crucial ...

A large 23andMe-based GWAS found that common variants in GLP1R and GIPR help explain why some people lose more weight or ...

Damaging variants in genes involved in a rapid immune response (innate immunity) are significantly linked to earlier breast ...

Learn why genetic testing is vital for ATTR-CM diagnosis, how it identifies hereditary risks for family members, and the ...